|
|
|
|
| LEADER |
01811cam a2200337 a 4500 |
| 001 |
99701327404151 |
| 005 |
20180418102138.0 |
| 008 |
051205s2005 dcu bj 001 0 eng |
| 010 |
|
|
|a 2005058156
|
| 016 |
7 |
|
|a 101270710
|2 DNLM
|
| 019 |
|
|
|a 67282203
|a 988714830
|a 1012053505
|
| 020 |
|
|
|a 9781570184949
|
| 020 |
|
|
|a 1570184941
|
| 024 |
3 |
|
|a 9781570184949
|
| 035 |
|
|
|a (OCoLC)62593819
|z (OCoLC)67282203
|z (OCoLC)988714830
|z (OCoLC)1012053505
|
| 035 |
|
|
|a (OCoLC)ocm62593819
|
| 040 |
|
|
|a DLC
|c DLC
|d BNA
|d C#P
|d BAKER
|d YDXCP
|d BTCTA
|d OCLCG
|d NLM
|d CGC
|d OCLCF
|d OCLCO
|d CHVBK
|d OCLCO
|d OCL
|d OCLCQ
|d OCL
|d CWCLL
|d OCLCO
|d OCLCQ
|d OCLCO
|d NJR
|d U@S
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a U@SA
|
| 050 |
0 |
0 |
|a KF3133.D78
|b T46 2005
|
| 082 |
0 |
0 |
|a 346.7304/86
|2 22
|
| 100 |
1 |
|
|a Thomas, John R.,
|d 1967-
|
| 245 |
1 |
0 |
|a Pharmaceutical patent law /
|c John R. Thomas.
|
| 260 |
|
|
|a Washington, D.C. :
|b Bureau of National Affairs,
|c 2005.
|
| 300 |
|
|
|a xxiv, 678 p. ;
|c 26 cm. +
|e 1 CD-ROM (4 3/4 plg.)
|
| 504 |
|
|
|a Incluye referencias bibliográficas e índice.
|
| 505 |
0 |
|
|a Introduction to pharmaceutical patents -- Patent eligibility -- Utility -- Novelty -- Nonobviousness -- The patent instrument -- Patent acquisition procedures -- Duration of rights -- The FDA drug approval process -- The orange book -- Marketing exclusivities -- Scope of patent rights -- Claim interpretation and the doctrine of equivalents -- Parallel importation -- The experimental use privilege -- Antitrust considerations -- International and comparative patent law -- International and comparative data protection law.
|
| 650 |
|
0 |
|a Drugs
|z United States
|v Patents.
|
| 650 |
|
0 |
|a Patent laws and legislation
|z United States.
|
| 650 |
|
7 |
|a Medicamentos
|z Estados Unidos
|v Patentes.
|2 UDESA
|
| 650 |
|
7 |
|a Patentes de invención
|x Legislación
|z Estados Unidos.
|2 UDESA
|